MRNA Moderna PE ratio, current and historical analysis

The current PE ratio of MRNA can't be determined, as the TTM EPS of -$9.28 is negative. The last recorded PE ratio for Moderna was 39.19 in June 2023.

MRNA PE ratio history

How has MRNA's PE ratio performed in the past

The average historical PE ratio of Moderna for the last five years is 22.07. Over the past five years, MRNA's PE ratio was at its highest in the Mar 2021 quarter at 90.31, when the stock price was $130.95 and the EPS was $1.45. The lowest value was in the Sep 2022 quarter, when it reached 4.03 with a price of $118.25 and an EPS of $29.37.

Today
N/A
Average
22.07
Median
10.49
Minimum
4.03
Maximum
90.31

Moderna PE ratio by year

Maximum annual increase: 0.84% in 2022

Year PE ratio PE change Price EPS
2024 N/A N/A $41.58 -$9.28
2023 N/A N/A $99.45 -$12.33
2022 8.45 0.84% $179.62 $21.26
2021 8.38 N/A $253.98 $30.31
2020 N/A N/A $104.47 -$1.96
2019 N/A N/A $19.56 -$1.55
2018 N/A N/A $15.27 -$4.95
2017 N/A N/A N/A -$4.18
2016 N/A N/A N/A -$3.79

Moderna PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Dec 2024 N/A N/A $41.58 -$9.28
Sep 2024 N/A N/A $66.83 -$5.81
Jun 2024 N/A N/A $118.75 -$15.37
Mar 2024 N/A N/A $106.56 -$15.66
Dec 2023 N/A N/A $99.45 -$12.33
Sep 2023 N/A N/A $103.29 -$9.1
Jun 2023 39.19 213.02% $121.5 $3.1
Mar 2023 12.52 48.17% $153.58 $12.27
Dec 2022 8.45 109.68% $179.62 $21.26
Sep 2022 4.03 -1.23% $118.25 $29.37
Jun 2022 4.08 -13.92% $142.85 $34.97
Mar 2022 4.74 -43.44% $172.26 $36.35
Dec 2021 8.38 -61.79% $253.98 $30.31
Sep 2021 21.93 -18.9% $384.86 $17.55
Jun 2021 27.04 -70.06% $234.98 $8.69

MRNA average PE ratio chart

What is the average PE ratio of MRNA for the past years
3-year avg
13.65
5-year avg
22.07
10-year avg
N/A
15-year avg
N/A

MRNA PE vs peers

What is MRNA's PE ratio compared to its peers
Stock name PE ratio Market cap
MRK Merck & Co Inc 12.24 $209B
JNJ Johnson & Johnson 17.06 $371.93B
NVS Novartis AG 18.94 $221.49B
RGLS Regulus Therapeutics Inc N/A $182.83M
ARWR Arrowhead Pharmaceuticals Inc N/A $1.67B
ALNY Alnylam Pharmaceuticals Inc N/A $32.57B
MRNA Moderna Inc N/A $10.5B

Frequently asked questions

What is Moderna's PE ratio?

The current price to earnings ratio of MRNA can't be calculated, as its EPS of -$9.28 is negative.

What is the 3-year average PE ratio for Moderna (MRNA)?

The 3-year average PE ratio for MRNA stock is 13.65.

What is the 5-year average PE ratio for Moderna (MRNA)?

The 5-year average PE ratio for MRNA stock is 22.07.

What is the highest PE ratio for MRNA?

In the last five years, the Mar 2021 quarter recorded the highest quarterly PE ratio at 90.31.

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.